Earnings NewsClearside Biomedical GAAP EPS of -$0.16 misses by $0.04, revenue of $0.3M beats by $0.2MMar. 09, 2023 4:34 PM ETClearside Biomedical, Inc. (CLSD)By: SA News Team Clearside Biomedical press release (NASDAQ:CLSD): Q4 GAAP EPS of -$0.16 misses by $0.04. Revenue of $0.3M (-98.8% Y/Y) beats by $0.2M. Recommended For YouCommentsNewestPublishHave a tip? Submit confidentially to our News team. Found a factual error? Report here.More Trending NewsThese are the most under-owned large-cap tech stocks - MSPDD surges on Q3 beat as Temu keeps wooing consumersS&P, Nasdaq, Dow futures tick lower with more housing, consumer data aheadCrowdStrike expected to beat and raise next 2 quarters: WedbushBiggest stock movers today: PDD Holdings, Carlyle Group, Zscaler and moreSee More »About CLSDSymbolLast Price% Chg1D5D1M6M1Y5Y10YMarket CapPEYield (TTM)Rev Growth (YoY)Short InterestPrev. CloseCompare to PeersRelated StocksSymbolLast Price% ChgCLSD--Clearside Biomedical, Inc.NGM--NGM Biopharmaceuticals, Inc.OCUP--Ocuphire Pharma, Inc.SCYX--SCYNEXIS, Inc.EYEN--Eyenovia, Inc.CompareTrending AnalysisTrending News